These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38840122)

  • 21. Investigation of carbapenem-resistant Enterobacterales isolates at a tertiary laboratory in Pretoria, South Africa.
    Ramashia M; Phofa TD; Nkawane GM; Nogbou ND; Bolukaoto JY; Nchabeleng M; Musyoki AM
    Acta Microbiol Immunol Hung; 2023 Dec; 70(4):295-303. PubMed ID: 37917156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment Outcome of Bacteremia Due to Non-Carbapenemase-producing Carbapenem-Resistant Klebsiella pneumoniae Bacteremia: Role of Carbapenem Combination Therapy.
    Lee NY; Tsai CS; Syue LS; Chen PL; Li CW; Li MC; Ko WC
    Clin Ther; 2020 Mar; 42(3):e33-e44. PubMed ID: 32061374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: Description of a decade-long trend.
    Balkhair A; Al-Muharrmi Z; Al'Adawi B; Al Busaidi I; Taher HB; Al-Siyabi T; Al Amin M; Hassan KS
    Int J Infect Dis; 2019 Aug; 85():10-15. PubMed ID: 31100418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes and genetic relatedness of carbapenem-resistant enterobacteriaceae at Detroit medical center.
    Marchaim D; Chopra T; Perez F; Hayakawa K; Lephart PR; Bheemreddy S; Blunden C; Hujer AM; Rudin S; Shango M; Campbell M; Varkey J; Slim J; Ahmad F; Patel D; Chen TY; Pogue JM; Salimnia H; Dhar S; Bonomo RA; Kaye KS
    Infect Control Hosp Epidemiol; 2011 Sep; 32(9):861-71. PubMed ID: 21828966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Investigation of Plasmid Mediated mcr Colistin Resistance Gene in Clinical Enterobacterales Isolates].
    Özkaya E; Buruk CK; Tosun İ; Toraman B; Kaklıkkaya N; Aydın F
    Mikrobiyol Bul; 2020 Apr; 54(2):191-202. PubMed ID: 32723275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems.
    Machuca I; Gutiérrez-Gutiérrez B; Gracia-Ahufinger I; Rivera Espinar F; Cano Á; Guzmán-Puche J; Pérez-Nadales E; Natera C; Rodríguez M; León R; Castón JJ; Rodríguez-López F; Rodríguez-Baño J; Torre-Cisneros J
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of colistin resistance and other predictors on fatality among patients with bloodstream infections due to Klebsiella pneumoniae in an OXA-48 dominant region.
    Menekşe Ş; Çağ Y; Işık ME; Şahin S; Hacıseyitoğlu D; Can F; Ergonul O
    Int J Infect Dis; 2019 Sep; 86():208-211. PubMed ID: 31402295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invasive carbapenem-resistant Enterobacteriaceae infection at a paediatric hospital: A case series.
    Malande OO; Du Plessis A; Rip D; Bamford C; Eley B
    S Afr Med J; 2016 Aug; 106(9):877-82. PubMed ID: 27601110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and Microbiological Outcomes in Obese Patients Receiving Colistin for Carbapenem-Resistant Gram-Negative Bloodstream Infection.
    Lam SW; Athans V
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31235624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and Bacterial Risk Factors for Mortality in Children With Carbapenem-resistant Enterobacteriaceae Bloodstream Infections in India.
    Nabarro LEB; Shankar C; Pragasam AK; Mathew G; Jeyaseelan V; Veeraraghavan B; Verghese VP
    Pediatr Infect Dis J; 2017 Jun; 36(6):e161-e166. PubMed ID: 28005691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for colistin-resistant Enterobacteriaceae in a low-endemicity setting for carbapenem resistance - a matched case-control study.
    Büchler AC; Gehringer C; Widmer AF; Egli A; Tschudin-Sutter S
    Euro Surveill; 2018 Jul; 23(30):. PubMed ID: 30064544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Outcomes and Treatment Strategies in Patients With Non-Carbapenemase-producing Carbapenem-Resistant Versus Carbapenem-Susceptible Enterobacterales Infections.
    Debnath A; Pillinger KE; Martin AJ; Dobrzynski D; Cameron A; Shulder S
    Ann Pharmacother; 2023 Jul; 57(7):803-812. PubMed ID: 36268974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical outcome of dual colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A single-center retrospective study of 75 cases in India.
    Kaur A; Gandra S; Gupta P; Mehta Y; Laxminarayan R; Sengupta S
    Am J Infect Control; 2017 Nov; 45(11):1289-1291. PubMed ID: 28807425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and Molecular Epidemiology of Carbapenem-Resistant Enterobacteriaceae Among Adult Inpatients in Singapore.
    Marimuthu K; Venkatachalam I; Khong WX; Koh TH; Cherng BPZ; Van La M; De PP; Krishnan PU; Tan TY; Choon RFK; Pada SK; Lam CW; Ooi ST; Deepak RN; Smitasin N; Tan EL; Lee JJ; Kurup A; Young B; Sim NTW; Thoon KC; Fisher D; Ling ML; Peng BAS; Teo YY; Hsu LY; Lin RTP; Ong RT; Teo J; Ng OT;
    Clin Infect Dis; 2017 May; 64(suppl_2):S68-S75. PubMed ID: 28475792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of rectal carbapenem resistant Enterobacterales carriage among patients attending healthcare facilities in Ibadan, Nigeria: a descriptive study.
    Adekanmbi O; Popoola O; Fowotade A; Idowu O; Ogunbosi B; Lakoh S; Adebiyi I; Ayandipo O; Iyun AO
    BMC Infect Dis; 2024 Jul; 24(1):726. PubMed ID: 39048999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of carbapenem-resistant Enterobacteriaceae and emergence of high rectal colonization rates of blaOXA-181-positive isolates in patients admitted to two major hospital intensive care units in Kuwait.
    Al Fadhli AH; Jamal WY; Rotimi VO
    PLoS One; 2020; 15(11):e0241971. PubMed ID: 33201906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and Microbiological Analysis of Risk Factors for Mortality in Patients with Carbapenem-Resistant Enterobacteriaceae Bacteremia.
    Seo H; Lee SC; Chung H; Ra SH; Sung H; Kim MN; Jung J; Kim MJ; Kim SH; Lee SO; Choi SH; Kim YS; Woo JH; Chong YP
    Int J Antimicrob Agents; 2020 Oct; 56(4):106126. PubMed ID: 32755654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. External validation of the INCREMENT-CPE mortality score in a carbapenem-resistant Klebsiella pneumoniae bacteraemia cohort: the prognostic significance of colistin resistance.
    Machuca I; Gutiérrez-Gutiérrez B; Rivera-Espinar F; Cano A; Gracia-Ahufinger I; Guzman-Puche J; Marfil-Pérez E; Pérez-Nadales E; Castón JJ; Bonomo RA; Carmeli Y; Paterson D; Pascual Á; Martínez-Martínez L; Rodríguez-Baño J; Torre-Cisneros J;
    Int J Antimicrob Agents; 2019 Oct; 54(4):442-448. PubMed ID: 31377343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of ceftazidime-avibactam versus colistin in treating carbapenem-resistant Enterobacteriaceae bacteremia.
    Hakeam HA; Alsahli H; Albabtain L; Alassaf S; Al Duhailib Z; Althawadi S
    Int J Infect Dis; 2021 Aug; 109():1-7. PubMed ID: 34091006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.